Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    14.05
    0.25 (1.81%)
    At close: Aug 21, 2025, 11:25 AM

    Crescent Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 11.81M 21.67M 44.35M
    Short-Term Investments
    		 n/a n/a 2.5M
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 29.03M 168K 472K
    Receivables
    		 19.59M 5M 1.82M
    Inventory
    		 6.34M n/a n/a
    Other Current Assets
    		 27.05M 1.54M 2.81M
    Total Current Assets
    		 64.79M 28.21M 51.48M
    Property-Plant & Equipment
    		 25.7M 70K 3.71M
    Goodwill & Intangibles
    		 273K n/a n/a
    Total Long-Term Assets
    		 60.62M 238K 4.19M
    Total Assets
    		 35.62M 28.44M 55.66M
    Account Payables
    		 108K 194K 6.42M
    Deferred Revenue
    		 n/a n/a 230K
    Short-Term Debt
    		 713K 38K 1.98M
    Other Current Liabilities
    		 15.86M 16.59M 5.54M
    Total Current Liabilities
    		 19.52M 16.82M 14.16M
    Long-Term Debt
    		 885K n/a 408K
    Other Long-Term Liabilities
    		 6.6M 33.31M n/a
    Total Long-Term Liabilities
    		 7.49M 33.31M 408K
    Total Liabilities
    		 27M 50.13M 14.57M
    Total Debt
    		 1.6M 38K 2.38M
    Common Stock
    		 1K 37K 31K
    Retained Earnings
    		 -73.45M -410.94M -402.69M
    Comprehensive Income
    		 -2.6M n/a n/a
    Shareholders Equity
    		 -15.48M -21.69M 41.09M
    Total Investments
    		 n/a n/a 2.5M

    Add to Watchlist